Stericycle (SRCL) Scheduled to Post Quarterly Earnings on Thursday

Stericycle (NASDAQ:SRCL) is scheduled to be releasing its earnings data before the market opens on Thursday, April 25th. Analysts expect Stericycle to post earnings of $0.53 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Wednesday, February 28th. The business services provider reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.07. The firm had revenue of $652.00 million for the quarter, compared to the consensus estimate of $657.99 million. Stericycle had a positive return on equity of 7.06% and a negative net margin of 0.80%. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.60 EPS. On average, analysts expect Stericycle to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Stericycle Stock Down 1.2 %

NASDAQ SRCL opened at $50.33 on Wednesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.94 and a current ratio of 0.94. Stericycle has a 52 week low of $37.78 and a 52 week high of $57.06. The stock has a market capitalization of $4.67 billion, a P/E ratio of -209.70, a price-to-earnings-growth ratio of 2.76 and a beta of 1.09. The stock has a fifty day moving average of $51.49 and a 200-day moving average of $48.15.

Analyst Upgrades and Downgrades

Several analysts have weighed in on SRCL shares. Royal Bank of Canada reissued an “outperform” rating and set a $69.00 price objective on shares of Stericycle in a report on Thursday, March 7th. Stifel Nicolaus increased their target price on Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, February 29th. Truist Financial upped their price objective on shares of Stericycle from $50.00 to $57.00 and gave the company a “hold” rating in a research report on Thursday, February 29th. Wells Fargo & Company raised their price objective on Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a research note on Friday, March 1st. Finally, StockNews.com cut Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Stericycle presently has an average rating of “Hold” and an average target price of $62.25.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.